Osmotica Pharmaceuticals is a biopharmaceutical company that develops and commercializes pharmaceutical products in the US, Argentina, and Hungary. Its products include treatments for ADHD, Parkinson's disease, multiple sclerosis spasticity, Blepharoptosis, and neurodegenerative disorders. It also provides women's health products and non-promoted products for various medical conditions. The company is headquartered in Bridgewater, New Jersey.